Literature DB >> 6164383

Choroidal neovascularisation induced by photocoagulation in sickle cell disease.

P I Condon, L M Jampol, S M Ford, G R Serjeant.   

Abstract

Choroidal neovascularisation occurred in 35 out of 57 (61%) patients during a trial of xenon are photocoagulation in proliferative sickle retinopathy. Nineteen patients manifested abnormal vessel systems in the plane of the retina which tended to be benign, not enlarging, and without complications (choroidoretinal neovascularisation). In 16 patients the abnormal vessel systems grew into the vitreous, tended to increase in size, and to be associated with vitreous haemorrhage and retinal traction (choroidovitreal neovascularisation). Both forms of neovascularisation were significantly more common at younger ages. Treatment was generally unsatisfactory, frequently resulting in further enlargement of the lesions. Although the natural history of choroidal neovascularisation and its ultimate effect on visual function remains to be recorded, these lesions constitute a common and potentially serious complication of xenon are photocoagulation in proliferative sickle retinopathy as currently performed.

Entities:  

Mesh:

Year:  1981        PMID: 6164383      PMCID: PMC1039462          DOI: 10.1136/bjo.65.3.192

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  6 in total

1.  Photocoagulation and diathermy in the treatment of proliferative sickle retinopathy.

Authors:  P I Condon; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1974-07       Impact factor: 4.638

2.  Argon laser photocoagulation of proliferative sickle retinopathy.

Authors:  M F Goldberg; I Acacio
Journal:  Arch Ophthalmol       Date:  1973-07

3.  Treatment of proliferative sickle retinopathy.

Authors:  M F Goldberg
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1971 May-Jun

4.  Ocular findings in homozygous sickle cell anemia in Jamaica.

Authors:  P I Condon; G R Serjeant
Journal:  Am J Ophthalmol       Date:  1972-04       Impact factor: 5.258

5.  Behaviour of untreated proliferative sickle retinopathy.

Authors:  P I Condon; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1980-06       Impact factor: 4.638

6.  Photocoagulation in proliferative sickle retinopathy: results of a 5-year study.

Authors:  P I Condon; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1980-11       Impact factor: 4.638

  6 in total
  8 in total

1.  Influence of genotype on the natural history of untreated proliferative sickle retinopathy--an angiographic study.

Authors:  P D Fox; S J Vessey; M L Forshaw; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1991-04       Impact factor: 4.638

2.  Treatment of iatrogenic choriovitreal neovascularisation in sickle cell disease.

Authors:  R W Acheson; P D Fox; E L Chuang; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1991-12       Impact factor: 4.638

3.  Idiopathic sub-retinal neovascular membranes in the macula (hemorrhagic macular choroidopathy of young adults). Clinical report and effectiveness of laser treatment.

Authors:  F G Bottoni; A F Deutman
Journal:  Doc Ophthalmol       Date:  1986       Impact factor: 2.379

4.  Iatrogenic choroidal neovascularisation following argon laser photocoagulation for choroidal malignant melanoma.

Authors:  Z I Currie; I G Rennie; J F Talbot
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-04       Impact factor: 3.117

5.  Spontaneous peripheral chorioretinal neovascularisation in association with sickle cell anaemia.

Authors:  J C Liang; L M Jampol
Journal:  Br J Ophthalmol       Date:  1983-02       Impact factor: 4.638

6.  Outcome of iatrogenic choroidal neovascularisation in sickle cell disease.

Authors:  P D Fox; R W Acheson; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1990-07       Impact factor: 4.638

7.  Argon and krypton laser photocoagulation of senile exudative macular degeneration.

Authors:  J A Oosterhuis
Journal:  Doc Ophthalmol       Date:  1983-02-28       Impact factor: 2.379

Review 8.  The past, present and future management of sickle cell retinopathy within an African context.

Authors:  Kwesi Nyan Amissah-Arthur; Evelyn Mensah
Journal:  Eye (Lond)       Date:  2018-07-10       Impact factor: 3.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.